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Abstract 
BACKGROUND: Behçet's syndrome is associated with inflammation of various areas of the body. Sy. Behcet is a 
rare, chronic, recurrent disease characterised by changes in the: Arteries that supply blood to the body's tissues, 
veins that take the blood back to the lungs, the back of the eye's retina, brain, joints, skin and bowels. There is a 
close correlation between the geographical distribution of HLA-B51 and its prevalence. In the etiopathogenesis, 
there are indications of genetic susceptibility associated with environmental influence. Although aetiology is not 
yet known, it is thought of viral or autoimmune genes but is not yet confirmed by relevant analysis.  
CASE REPORT: This was a case of a 29 years old young female presenting with recurrent oral and genital 
ulcers. Eye lesions usually start in one eye and then pass to the other eye. They are like iridocyclitis extending 
very quickly to another eye. Three months later, a few shifts were introduced in the form of small initial ulcers, 
which for 4-5 days have been enlarged and then epithelized by leaving the catapult in the genital mucus. In the 
skin of the lower extremities, papules appear to be as large as corn grain. 
CONCLUSION: Diagnosis of Behçet's syndrome is determined based on eye changes, oral mucous and genital 
mucosa. Treatment of Behçet's syndrome depends on the severity and the location of its manifestations. 
 
 
 
 
 
 
 
 
 
 
 
Introduction 
 
Described in 1937 by the Turkish 
dermatologist Hulusi Behçet as a triad that associated 
uveitis with oral and genital aphthosis, it had been 
known since the fifth century BC, and its description 
can be found in the Hippocratic third book of endemic 
diseases. Since then, other manifestations have been 
described and added besides new aspects of 
epidemiology, immunopathogenesis, and treatment 
[1]. 
The highest of Behcet's disease (BD) 
prevalence ratios were found in Turkey, and its 
incidence is rare in the West (0.64/100,000 population 
in the United Kingdom and 0.12-0.33/100,000 in the 
United States). 
In general, BD has a peak age of onset 
between 20-30 years and patients who develop the 
disease from a very young age present with more 
severe forms, with more organs affected. However, 
that study did not show the severity or extent of the 
disease [11]. 
Behcet's disease is a rare, chronic, recurrent 
disease characterised by an atopic artery in the mouth 
mucus, genital mucus ulcerations and eye changes 
(hypopyon-iritis, conjunctivitis) [1] [2] [3]. 
These are major symptoms, accompanied by 
other symptoms in the skin in the form of 
erythematosus, disseminated papillomas, pustules 
and purple and nodose shifts [4] [5]. 
In addition to the skin, other organs such as 
rheumatoid arthritis, thrombophlebitis, gastrointestinal 
disorders, kidney, respiratory system, CNS changes 
with symptoms such as psychiatric 
meningoencephalitis and psychogenic alterations [6] 
[7] [8] [9]. 
Aetiology: It is not known, though in the viral 
or autoimmune genesis, but is not yet confirmed by 
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relevant analysis [3]. 
Mucocutaneous manifestations are markers 
of BD, and their recognition may allow diagnosis and 
treatment [1] Oral ulcers are present in almost all 
cases. These lesions are the initial manifestation in up 
to 80% of the patients and precede subsequent ones 
in an average of 7-8 years. Changes in buccal mucus 
usually start one by one in the shape of the beds 
covered with a white layer of yellow that is surrounded 
by erythema. They are accompanied by pain; they are 
classified by size and arrangement into minor (< 1 
cm), major, and herpetiform ulcers [1] [6] [7]. 
Genital lesions are similar to those in buccal 
mucous. However, they are less recurrent, have a 
greater tendency towards scar formation, and some 
exhibiting necrotic borders. Deeper lesions may 
complicate the onset of fistulas, especially in females 
with the possibility of being deeper and deeper [5] [6] 
[10] [12]. In women, ulcers in the vagina and colon 
can be oligosymptomatic. The most frequently 
involved region is the major labia [13]. 
Ocular disease, more common among men, affects 
the retina and uvea, occurring in 30-70% of patients, 
causing blindness in 25% of them. It usually appears 
2-3 years after oral and genital ulcers, but maybe the 
first manifestation of the disease in 10-20% of cases. 
Eye lesions usually start in one eye and then pass to 
the other eye. They are like iridocycles associated 
with hypophysiology, extending very quickly to other 
eye structures and, consequently, blindness [8] [9]. 
Although cutaneous lesions are non-specific 
for BD, they are essential for diagnosis. Their 
frequency varies from 48-88% in diagnosed patients 
[14]. Cutaneous manifestations can be divided into 
papulopustular lesions, erythema nodosum lesions, 
thrombophlebitis, and varied cutaneous and vasculitic 
lesions. Erythema nodosum (EN) lesions occur in 
one-third of patients, typically affecting the lower 
limbs.  
Neurological impairment occurs in 5-10% of 
the patients, affecting mostly men. It occurs about five 
years after the onset of the disease mainly affecting 
the central nervous system and the peripheral 
nervous system to a lesser extent. 
Deep vein thromboses of the extremities are 
the most common form of vascular involvement 
together with recurrent superficial venous thrombosis. 
Men are more affected than women. 
Joint involvement is reported in 45-60% of BD 
patients and includes arthralgia and non-erosive and 
non-deforming monoarthritis or polyarthritis. It affects 
knees, ankles, hips, elbows, wrists with neutrophilic 
and mononuclear inflammatory synovial infiltrates and 
thrombosis of small vessels. 
The gastrointestinal tract is affected in 3-26% 
of patients, varying in different populations, being 
more frequent in Japan than in the Middle East and 
the Mediterranean. 
Diagnosis is determined based on eye 
changes, oral mucus and genital mucus [2] [3]. 
The main objective of BD patient treatment is 
to induce and maintain remission and improve quality 
of life, preventing irreversible damage and 
exacerbation of mucocutaneous and articular disease 
[15] [16]. Its main premise is to eliminate inflammation 
and comprises the use of immunosuppressive agents 
in severe, life-threatening, and symptomatic 
manifestations in mucocutaneous and articular 
diseases [17]. Is not easy and sometimes does not 
give complete and quick results. 
Local: Fluorinated corticosteroids, nitric silver 
digestion, local anaesthetics are used. 
Systemic: Corticosteroids, sulfonate preparations 
(Dapsoni), gamaglobulin, large doses of vitamin C. [1] 
[2] [3]. 
The purpose of presenting this case with M. 
Behçet is to sensitise interdisciplinary cooperation for 
the benefit of the patient, to think more often in this 
disease, family doctors, dermatologists, dentists, 
ophthalmologists and gynaecologists. 
 
 
Case Presentation 
 
Patient X is 29 years old, housewife, married, 
and mother of three children. She is hospitalised at 
the Dermatovenerology Clinic. 
Anamnesis morbi: Accepted in the clinic due 
to changes in mouth mucus and genitals and 
erythema nodosum in the lower extremities. 
The disease started for the first time a year 
ago, first with mucus in the mouth on the inside of the 
lower lip, in the form of corrosion followed by the door, 
the temperature and the pain. 
The changes have stayed for a week and 
have been withdrawn, but have also been introduced 
in other places of mouth and tongue mucus. While 
visiting the dentist has used some Hexoral solutions 
for disinfection, vitamin C and antibiotics, little 
changes are calm but not entirely. 
Eye lesions usually start in one eye and then 
pass to the other eye. They are like iridocyclitis 
associated with hypophysiology, extending very 
quickly to another eye. 
Three months later, a few shifts were 
introduced in the form of small initial ulcers, which for 
4-5 days have been enlarged and then epithelized by 
leaving the catapult in the genital mucus. They have 
been associated with great pain in the affected area. 
Having been hospitalised in gynaecology because of 
these changes has been postponed for a month, 
received antibiotics in ampoules and has used 
vaginitis due to increased secretion. The situation has 
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slightly improved, but not entirely. 
 
Figure 1: Conjunctivitis chronic recidivans 
 
In the lower lip of the mucous membrane on 
the left side, there is erosion limited by a healthy 
mucous membrane, as large as a medium plaque. In 
the genital mucosa at the side of the left side there is 
a perforation with a diameter of 1 x 1 cm in round 
shape, and in the mucous membrane at the entrance 
of the vagina on the left side shows an erosion with a 
clear limit of irregular shape, diameter 1.5 x 0.5 cm 
with white suture on the yellow. On the right side of 
the large lips, a catheter is visible after the ulceration 
(Figure 2, 3). 
 
Figure 2: Ulcus vulvae (perforatio labia minor) 
 
In the skin of the lower extremities, papules 
appear to be as large as corn grain, some above the 
skin level, some below the skin level, and 
hyperpigmentations at the stage of transition to the 
earliest poppies (Figure 4). 
Laboratory analyzes: SE = 9/16; Leukocyte 
Formula: Er = 3.7 million cells/mcL, Ne = 60%, Ly = 
32%, Mo = 4%, Eu = 4%; Hg = 74%, Urea = 4.6 
mmol/L, Glycaemia = 5.3 mmol/L; Le = 14.3x10
9
/L 
Kreatinin = 60 mmol/L; Chol = 3.5 mmol/L; IgG = 1307 
mg/dl (1800 mg/dl); IgA = 462↑ mg/dl (450 mg/dl); IgM 
= 225 mg/dl (230 mg/dl); IgE = 25.4 mg/dl (1-183 
mg/dl); C3 = 161↑ mg/dl (135 mg/dl); C4 = 30 mg/dl; 
Anti DNA +. 
 
Figure 3: Cicatrix post ulcus vulvae 
 
Urine: Turbid, yellow, sour, sediment; 
enormous amorphous urate salts, 8-10 leukocytes, 
frequent bacteria, 10-15 epithelial cells. 
Vaginal stripe: Enterococcus, Escherichia coli. 
Stroke of the ulcer: Staphylococcus aureus. 
 
 
Figure 4: Erythema nodosum extremitas inferior billateralis 
 
Ophthalmologist: Conjunctivitis chronica 
recidivans. 
The patient was treated with: Amp. Nirypan 
80 mg, 5 days/amp. 40 mg + 
Tab. Pronison a 5 mg/day reduces the dose every 5 
days by 5 mg Nystatin salt for the oral, Tab. 
Erythromycin 500 4 x 1/two weeks, 
Vit C 3 x 2, vaginalete Geonistin 1 x 1 two weeks. 
The patient is released significantly improved. 
 
 
Discussion 
 
Is known that Behçet syndrome is a rare, 
chronic, recurrent disease characterized by three 
major symptoms: (1) stomatitis aphtous; (2) genital 
mutilation; (3) the conjunctiva, iridocyclitis in the eye, 
as well as accompanying symptoms in other organs 
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[1] [2] [3] [7] [8]. 
Based on the history and clinical picture it has 
been questioned whether it is pemphigus vulgaris, 
erythema exudative multiforme, or ulcus acutum 
vulvae [4] [5]. In our case - based analysis report, 
history and literature consultations, we have 
concluded that we are dealing with oculo-bucco-
genital Behçet-Syndrome. 
Behçet disease is a heterogeneous and yet 
intriguing disease. Despite the remarkable progress in 
research, many gaps need to be fulfilled. New 
knowledge regarding its immunopathogenesis, 
genetics, and epidemiology will greatly help in the 
development of laboratory tests, diagnostic criteria, 
activity indexes, and especially in the choice of the 
best treatment. 
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